Vimarsana
Biggest News Aggregation in the World

Page 6 - Opus Genetics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Opus Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Opus Genetics Today - Breaking & Trending Today

LaunchBio's Invest in Cures Forum Shines Light on the Rise Of Impact Investing | North Carolina Biotechnology Center - Vimarsana News

LaunchBio's Invest in Cures Forum Shines Light on the Rise Of Impact Investing | North Carolina Biotechnology Center

Impact investing is on the rise, and local pharmaceutical industry insiders presenting as part of a “who’s who” speaker lineup at LaunchBio’s recent Invest in Cures forum say it’s already paying off.

Foundation Fighting Blindness Promotes Jason Menzo to President and Chief Operating Officer - Vimarsana News

Foundation Fighting Blindness Promotes Jason Menzo to President and Chief Operating Officer

/PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization committed to finding treatments and cures for blinding retinal diseases,...

Foundation Fighting Blindness Promotes Jason Menzo to President and Chief Operating Officer - Vimarsana News

Foundation Fighting Blindness Promotes Jason Menzo to President and Chief Operating Officer

/PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization committed to finding treatments and cures for blinding retinal diseases,...

Startup spotlight: Opus Genetics, with $19M, works to advance cures for blinding retinal diseases - Vimarsana News

Startup spotlight: Opus Genetics, with $19M, works to advance cures for blinding retinal diseases

RALEIGH - Opus Genetics recently announced it would open its third preclinical trial, just a few months after the company formed with a $19 million seed

Raleigh startup Opus Genetics, with $19M in funding and new execs, to begin 3rd preclinical trial - Vimarsana News

Raleigh startup Opus Genetics, with $19M in funding and new execs, to begin 3rd preclinical trial

RALEIGH - Opus Genetics, launched earlier this year with $19 million in invested capital, has signed an agreement to license its third preclinical program from